Accessibility StatementSkip Navigation Novo Nordisk Amended Proposal Values Metsera at up to $86.20 per Share, a Total of Approximately$ 10.0 Billion Pfizer Merger Agreement Remains in Effect; No Action Required by Metsera Shareholders Superior to Revised Pfizer Proposal that Valued Metsera at up to $70.00 per Share, a Total of Approximately$ 8.1 Billion Pursuant to Pfizer Merger Agreement, Metsera and Pfizer May Negotiate Potential Adjustments for Two Business Days NEW YORK, Nov. 4, 2025 /PRNewswire/ - ...